Whitepapers

May 18, 2015
As the healthcare industry undergoes significant change, physicians and other healthcare providers are forced to find new ways to stay informed and meet increased demands. To help them, their circle of influence has widened, including digital sources, social media, online forums, traditional journal articles by key opinion leaders, and even the patients themselves. Meanwhile, pharmaceutical companies are looking for new opportunities of their own to help get their products in front of a new generation of healthcare providers. Discover the right tools to help do it.
May 18, 2015
Discover seven reasons why pharmaceutical marketers who want to keep up with the changing healthcare environment must embrace modern marketing technology to help them, including marketing cloud technology alongside a cross-channel marketing strategy for pharmaceutical sales.
May 18, 2015
In the world of pharmaceutical sales and marketing, communications have traditionally been measured as either “personal” or “non-personal”, and the division between the two was distinct. Personal communications were handled by the sales department, while marketing took care of the non-personal. Today, though, personal interactions are becoming more difficult to arrange, while non-personal interactions have become more pervasive. Discover how modern marketing tools can add a personal touch.
May 12, 2015
Pharmaceutical Executive
When it comes to supporting the clinical and marketing objectives of a pharmaceutical franchise, removing potential barriers for patients and providers is a primary focus for any brand team. How are manufacturers using hub model programs to maximize brand access and adherence?
Apr 30, 2015
Pharmaceutical Executive
This whitepaper discusses the importance of observational research and patient registries in evidence generation. The modern healthcare environment is a mosaic of stakeholders, each with remarkably different demands for data addressing product attributes. These often conflicting perspectives require access to a portfolio of interventional and observational research designs sub-serving different objectives … Increasingly central is the inclusion of observational studies, including registries, which provide insights missing from traditional interventional studies encountered in the course of drug development.
Apr 29, 2015
Pharmaceutical Executive
When it comes to supporting the clinical and marketing objectives of a pharmaceutical franchise, removing potential barriers for patients and providers is a primary focus for any brand team. How are manufacturers using hub model programs to maximize brand access and adherence?
Apr 16, 2015
Pharmaceutical Executive
Hubs provide an array of services and solutions to multiple stakeholders throughout a patient’s treatment. What should manufacturers look for when hiring a hub?
Apr 12, 2015
Pharmaceutical Executive
Drug development has never before been so difficult, time consuming and expensive. Accuracy in clinical trials, therefore, is a priority. However, suboptimal adherence is prevalent in ambulatory trials, in which outpatients are responsible for taking the drug according to the protocol-specified dosing regimen. Unfortunately, most methods for measuring medication adherence are inaccurate, which can result in costly phase III failures. This whitepaper focuses on a proven exception—automatic adherence measurement through electronic compilation of drug dosing histories. Electronic measurement enables a better understanding of drug safety and efficacy data, improving the likelihood of a successful trial outcome and more informed development decisions, leading to faster speed to commercialization.
Mar 23, 2015
By studying the companies that succeed, Oracle has identified four areas where they have created advantages not related to product innovation. These areas are ones that any company can emulate and implement every day. The metrics provide insight into top-level corporate and operational health.
Mar 23, 2015
Pharmaceutical marketers need to find a new way to offer modern, personalized marketing content that will help them get their message across to the right people, but remain HIPAA compliant at the same time.